Cold Pain Therapy Market Analysis by Global Industry Growth, Regions, Types and Forecasts 2023

Get Free Sample Research Copy @

The Global Cold Pain Therapy Market is projected to reach USD 2.12 billion by 2023 from USD 1.69 billion in 2018, at a CAGR of 4.6%. This report spread across 273 Pages, Profiling 15 Companies and Supported with 106 Tables and 126 figures are now available in this research.


Top Key Players Profiled in the Cold Pain Therapy Market:

  • Sanofi (France)
  • DJO Finance (US)
  • Pfizer (US)
  • 3M (US)
  • Hisamitsu Pharmaceutical (Japan)
  • Johnson & Johnson (US)
  • Medline Industries (US)
  • Össur (Iceland)
  • Performance Health (US)
  • Beiersdorf (Germany)
  • Rohto Pharmaceutical (US)
  • Breg (US)
  • Romsons Group of Industries (India)
  • Custom Ice (US)
  • Unexo Life Sciences (India)


The OTC products segment accounted for the larger share of the global cold pain therapy market in 2017. This can be attributed to factors such as high patient preference for topical pharmaceuticals compared to oral medications owing to its lower side effects, fast pain relief, and convenience in use.


Access Full report @


The market is segmented into musculoskeletal disorders, post-operative therapy, sports medicine, and post-trauma therapy on the basis of application. In 2017, the musculoskeletal disorders segment is growing at the highest CAGR during the forecast period. The increasing incidence of arthritis, osteoarthritis, back pain, and joint pain; rising geriatric population; increasing trend of self care; and the growing preference for topical analgesics to manage musculoskeletal pain are some of the major factors driving the growth of this market segment.


Competitive Landscape of Cold Pain Therapy Market:

1 Introduction

2 Market Share Analysis

3 Competitive Scenario

4 Recent Developments

4.1 New Product Launches

4.2 Agreements, Partnerships, and Contracts

4.3 Expansions




Ask Question @

Share This Post